Evidence map›Paper›PMID 36769175›Full record

ReviewInternational journal of molecular sciences2023

Kidney Drug Transporters in Pharmacotherapy.

Joanna Łapczuk-Romańska, Maria Droździk, Stefan Oswald, Marek Droździk

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. An AOP-guidedNAM journal · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joanna Łapczuk-RomańskaDepartment of Pharmacology, Pomeranian Medical University, Powstancow Wlkp 72, 70-111 Szczecin, Poland.ORCID 0000-0002-2027-0687
Maria DroździkMedical Faculty, Medical University of Lodz, Tadeusza Kościuszki 4, 90-419 Lodz, Poland.
Stefan OswaldInstitute of Pharmacology and Toxicology, Rostock University Medical Center, 18051 Rostock, Germany.ORCID 0000-0001-6269-4368
Marek DroździkDepartment of Pharmacology, Pomeranian Medical University, Powstancow Wlkp 72, 70-111 Szczecin, Poland.ORCID 0000-0002-6191-7168

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The kidney functions not only as a metabolite elimination organ but also plays an important role in pharmacotherapy. The kidney tubule epithelia cells express membrane carriers and transporters, which play an important role in drug elimination, and can determine drug nephrotoxicity and drug-drug interactions, as well as constituting direct drug targets. The above aspects of kidney transport proteins are discussed in the review.

Indexed as

Drug-Related Side Effects and Adverse ReactionsOrganic Anion TransportersCarrier ProteinsDrug InteractionsHumansKidneyMembrane Transport ProteinsCarrier ProteinsMembrane Transport ProteinsOrganic Anion Transportersdrug transporterskidney

Identifiers

PMID36769175
PMCPMC9917665

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.